Australia’s 1st monoclonal antibody biosimilar approved by the TGA

TGA has approved Australia’s 1st monoclonal antibody biosimilar INFLECTRA infliximab (rmc) 100mg Powder for Injection vial, a biosimilar medicine. On the ARTG 19th August 2015.

Comments Off on Australia’s 1st monoclonal antibody biosimilar approved by the TGA